NCT03619876View on ClinicalTrials.gov

Effects of Abatacept on Myocarditis in Rheumatoid Arthritis

PHASE4TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 10, 2019

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
Rheumatoid ArthritisMyocardial Inflammation
Interventions
DRUG

Abatacept

125 MG/ML subcutaneous injections

DRUG

Adalimumab

40 Mg/0.8 mL Subcutaneous Kit

Trial Locations (1)

10023

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Columbia University

OTHER